AGP Executive Report
Last update: 9 hours agoTransplant drug deal: Hansa Biopharma and SERB signed an exclusive licensing agreement for IDEFIRIX (imlifidase) covering the EU, UK, Switzerland, Norway, Liechtenstein, Iceland and MENA, with SERB paying €110m upfront plus €5m on EMA filing acceptance—aimed at desensitizing highly sensitized kidney transplant patients. Diplomacy & energy: Prime Minister Narendra Modi arrived in Oslo for the India–Nordic Summit as India and Norway agreed a “green strategic partnership” on clean energy, climate resilience, the blue economy and green shipping, with business leaders urging smoother approvals and “ground level” regulatory fixes. Local governance watch: In the UK, a Lancashire police officer was sacked for supervising a learner driver while over the drink-drive limit. Health policy abroad: Pfizer’s HYMPAVZI (marstacimab) gained an expanded EU authorization for hemophilia patients with inhibitors aged 12+ (≥35kg).
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result.
Perspectify News
.webp)
